Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ.
Wile DJ, et al.
Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20.
Lancet Neurol. 2017.
PMID: 28336296
Free PMC article.
Striatal dopamine transporter binding, VMAT2 binding, (18)F-FDOPA uptake, and serotonin transporter binding in multiple brain regions were compared by ANCOVA, adjusted for age. ...LRRK2 mutation carriers without manifest Parkinson's disease (n=25) had greater (18)F- …
Striatal dopamine transporter binding, VMAT2 binding, (18)F-FDOPA uptake, and serotonin transporter binding in multiple brain regions …